CA
AZN icon

Cetera Advisors’s AstraZeneca AZN Stock Holding History

Cetera Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$6.66M Buy
49,131
+27,244
+124% +$3.61M 0.05% 363
2023
Q4 		$2.95M Buy
21,887
+11,878
+119% +$1.54M 0.04% 397
2023
Q3 		$1.36M Buy
10,009
+202
+2% +$27.6K 0.02% 609
2023
Q2 		$1.4M Sell
9,807
-2,766
-22% -$407K 0.02% 597
2023
Q1 		$1.75M Buy
12,573
+22
+0.2% +$2.96K 0.03% 496
2022
Q4 		$1.7M Sell
12,551
-2,471
-16% -$310K 0.03% 496
2022
Q3 		$2K Buy
15,022
+7,953
+113% +$1.01M ﹤0.01% 1297
2022
Q2 		$934K Sell
7,069
-246
-3% -$32.3K 0.02% 595
2022
Q1 		$971K Buy
7,315
+33
+0.5% +$3.96K 0.02% 623
2021
Q4 		$848K Sell
7,282
-2,697
-27% -$317K 0.02% 667
2021
Q3 		$1.2M Buy
9,979
+1,726
+21% +$201K 0.02% 548
2021
Q2 		$989K Buy
8,253
+3,410
+70% +$374K 0.02% 553
2021
Q1 		$482K Sell
4,843
-176
-4% -$17.7K 0.01% 760
2020
Q4 		$502K Buy
5,019
+211
+4% +$22.3K 0.02% 639
2020
Q3 		$527K Buy
4,808
+392
+9% +$43.6K 0.02% 537
2020
Q2 		$467K Sell
4,416
-5,625
-56% -$581K 0.02% 553
2020
Q1 		$897K Buy
10,041
+862
+9% +$81.1K 0.05% 341
2019
Q4 		$919K Sell
9,179
-148
-2% -$13.9K 0.04% 389
2019
Q3 		$827K Sell
9,327
-332
-3% -$28.8K 0.04% 403
2019
Q2 		$795K Buy
9,659
+932
+11% +$73.1K 0.04% 442
2019
Q1 		$706K Buy
8,727
+4,264
+96% +$336K 0.04% 403
2018
Q4 		$339K Buy
+4,463
New +$349K 0.02% 597

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cetera Advisors's AZN Position: Q1 2024 in Review

Cetera Advisors increased its AstraZeneca (AZN) stake by 124% in Q1 2024, buying an estimated $3.61M and bringing the position to 49,131 shares worth $6.66M. The position accounts for 0.05% of the portfolio, ranked #363.

Cetera Advisors first reported a position in AZN in Q4 2018 and has held it in 22 quarters since. 1,141 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

  • Cetera Advisors held 49,131 shares of AstraZeneca worth $6.66M as of Q1 2024.
  • Cetera Advisors bought 27,244 AstraZeneca shares in Q1 2024, an estimated $3.61M.
  • AstraZeneca made up 0.05% of Cetera Advisors's portfolio in Q1 2024, its #363 holding.
  • Cetera Advisors first reported a position in AstraZeneca in Q4 2018 and has held it in 22 quarters since.
  • 1,141 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.